Beijing Wantai Biological Stock Hits Day Low Amid Price Pressure at CNY 28.90

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. experienced a significant decline today, with the stock dropping by 6.68% and reaching an intraday low of CNY 28.90. This performance is notably below the China Shanghai Composite, which saw a modest decrease of 0.16% on the same day. Over the past week, Beijing Wantai has faced a steep decline of 13.77%, and its one-month performance reflects a staggering drop of 37.35%. Year-to-date, the stock has lost 35.63%, and its one-year performance shows a decline of 57.13%. The company has consistently underperformed against the benchmark, with a three-year performance down by 56.46%. Financial metrics indicate ongoing challenges, with net sales for the last nine months declining by 22.74% and a net profit of CNY -134.9 million, reflecting a significant drop of 202.52%. The company has reported negative results for the last eight consecutive quarters, highlighting a trend of underperformance in the pharmaceuticals and biotechnology sector. With a market capitalization of CNY 42,471 million, Beijing Wantai continues to navigate a difficult financial landscape.